window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : October 19, 2025

  • News
  • About Us
Contact Us

Oculis

  • Clinical Trials

    Oculis completes enrollment in DIAMOND Phase 3 trials of OCS-01 for diabetic macular edema

    June 4, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2025 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • MaxCyte signs platform licence with Moonlight Bio to advance T cell therapies for solid tumours
    Categories: Biotech, Cell & Gene Therapy, Partnerships & Funding, Research & Development
  • Nordic Life Science Days 2025 opens in Gothenburg with calls for deeper collaboration and global investment
    Categories: European biotech, Events and Conferences, Global health, Healthcare leadership, Market Access & Commercialization, Partnerships & Funding, Research & Development
  • New AI tool offers real-time insights into clinical trial participant behavior
    Categories: Artificial Intelligence, Clinical Development, Digital Health, Drug Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top